Primary Prevention with Aspirin: Lowering ASCVD Mortality in Adults with Elevated Lipoprotein(a) Dr Prakash Kumar19 Nov 2024 9:15 AM ISTQuick Takeaways:Elevated Lp(a) (>=50 mg/dL) significantly raises ASCVD risk, affecting around 25% of Indians.One-time Lp(a) screening in adulthood...
The Role of Aspirin in Reducing ASCVD Mortality Among Adults with High Lp(a) Concentrations Dr A B Chandorkar8 Aug 2024 11:00 AM ISTAtherosclerotic cardiovascular disease (ASCVD) burden in young individuals is a major health concern, particularly in less developed nations where...
Evaluating the Benefits of Aspirin in Lowering ASCVD Mortality for Elevated Lp(a) Individuals Dr. Prem Aggarwal4 July 2024 12:22 PM ISTAtherosclerotic cardiovascular disease (ASCVD) among young adults is a major public health challenge with a global prevalence of 7% to 30%. (1) Due to...
